glp 1 receptors in the body Glucagon-like peptide-1 receptor: mechanisms and advances therapy Science Behind GLP 1 GIP

Ryan-Harshman M, Aldoori W

The burden of proof shifts

This drug may cause side effects, including nausea/vomiting, diarrhea, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, gas, hair loss, GERD, abdominal distension, dizziness, and low blood pressure

Compared to the control group, they exhibited greater improvement in Psoriasis Area Severity Index (PASI) and Dermatology Life Quality Index (DLQI)

Specifically, nanozymes can induce immunogenic cell death through various mechanisms, such as alloy nanoparticles like Cu-Ag NPs [136] or FeCu-DA [137], as well as nanozyme platforms [138]